Insider filing · ARDX

David P. Rosenbaum sold $343K of Ardelyx (ARDX)

Executed Sep 27 2024, disclosed Oct 1 2024, 4 days later.

Returns are measured on stock purchases only.

DR David P. Rosenbaum Chief Development Officer profile →

David P. Rosenbaum (Chief Development Officer) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Ardelyx, Inc. (ARDX). The largest single filing was $343K of ARDX (49,564 sh × $6.92, as filed), executed Sep 27 2024.

ARDX Ardelyx, Inc. ARDX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→